Alfalastin (LFB SA)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlfalastin (LFB SA)
Drug Alias NameAlfalastin
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAlpha-1-antiproteinase inhibitors
TargetsAlpha-1-antiproteinase
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved Indicationsalpha 1-Antitrypsin Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2005/08/01
Country/TerritoryFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLfb Biotechnologies Sas
China Registration ClassN/A

Develop Information

Active CompaniesLfb Biotechnologies Sas
Inactive CompaniesN/A
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeB02AB02
Related LinksN/A